|
New Corporate Identity Unveiled... Sharing Vision for Leap to a Global Pharmaceutical and Bio Company
2022.03.29
|
|---|
|
Daehan Nupharm unveiled its new Corporate Identity (CI).
The new symbol represents the company’s initial ‘D’ as a cell, the basic unit of life, extending outward. The English name was changed from New Pharm to Nupharm, creating a single word without changing pronunciation.
Founded in 1984, Daehan Nupharm started with animal feed additives and has grown into a mid-sized pharmaceutical and bio company listed on KOSDAQ, operating in human pharmaceuticals, veterinary medicines, biopharmaceuticals, medical devices, and health supplements. The company has maintained an average annual growth rate of 15% over the past decade, reaching sales of 166.5 billion KRW in 2021 and consistently exceeding 10 billion KRW in exports since receiving the ‘Ten Million Dollar Export Tower’ award in 2015.
To enhance research capabilities and improve work environments, Daehan Nupharm completed its Industry-Academia-Research Center in the 2nd Pangyo Techno Valley and relocated its Hwaseong Central Research Institute and Osong Bio Research Institute to Pangyo, fostering synergy across divisions. The company is also constructing a new research building at its headquarters in the Hyangnam Pharmaceutical Industrial Complex this year.
Alongside the new CI, Daehan Nupharm launched the <BUILD UP 2025> campaign, sharing a vision to grow together with employees and become a global pharmaceutical and bio company that spreads warmth. The focus is on discovering future growth engines and enhancing core competencies in each division to ensure sustainable growth. |


Home